Skip to main content

Roan Capital Partners

Location
JOHNSON CITY, TN
Portfolio Value
Micro $1,575,387
Diversification
Moderately concentrated
Filing Date
Mar 31, 2026
Global Rank
#7,223 / 8,232
Top Industry
Drug Manufacturers - General 23.5%
3Y Alpha vs SPY
-95.7%
Period ended 2 months ago
Filed Apr 16, 2026 · 58d

Clone Performance

May 2026–Jun 2026 · vs SPY

Hypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.

Cloned portfolio
-5.9%
SPY
+0.2%
Annualised alpha
Max drawdown
−6.3%

Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.

Portfolio Concentration

23 positions · as of Mar 31, 2026
Top Position
30.5%
of portfolio value
Top 5
76.2%
of portfolio value
Top 10
86.3%
of portfolio value
HHI
1,861
Moderately concentrated

Sector Breakdown

As of Mar 31, 2026
Sector % Portfolio Value
Unclassified 71.9% $17,643,640
Healthcare 6.6% $1,619,760
Technology 6.4% $1,575,387
Consumer Defensive 4.5% $1,103,964
Financial Services 3.5% $847,198
Energy 3.2% $789,209
Industrials 2.1% $517,090
Communication Services 1.8% $449,391

Portfolio Positions

Export CSV View 13F filing
4 positions · $1,575,387 total · Technology only · as of Mar 31, 2026
Ticker Company Shares Value (USD) % of Portfolio History